Clinical Inertia: A Wider Perspective and Proposed Classification Criteria

Clinical inertia is very common in day-to-day practice, and the factors contributing to that can be physician-related, patient-related, or health-care-related. Clinical inertia is commonly described in chronic asymptomatic illness. We searched the PubMed and Scopus databases for original articles and reviews. Based on the search result, in this review article, we redefine various terminologies to avoid confusion and propose classification criteria for the early identification of clinical inertia. Clinical inertia is also present in acute illness and in symptomatic disease. Early identification of clinical inertia is difficult because of very vague terminologies which have been used interchangeably as well as because of the lack of definitive classification criteria. In this article, we redefine clinical inertia and propose criteria for early identification, which will be useful for both clinicians and academicians. This review will help clinicians to identify and rectify various aspects of clinical inertia.

[1]  V. Ravindran,et al.  Clinical Inertia in Rheumatology Practice , 2021, The journal of the Royal College of Physicians of Edinburgh.

[2]  Raveendran Arkiath Veettil Understanding Clinical Inertia in Diabetes , 2019, Journal of Social Health and Diabetes.

[3]  Matthew H Samore,et al.  ED Door‐to‐Antibiotic Time and Long‐term Mortality in Sepsis , 2019, Chest.

[4]  K. Khunti,et al.  Deintensification in older patients with type 2 diabetes: A systematic review of approaches, rates and outcomes , 2019, Diabetes, obesity & metabolism.

[5]  V. Mohan Expanding the concept of ‘Clinical Inertia’ in diabetes , 2019, Journal of Diabetology.

[6]  H. Schønheyder,et al.  Time to antibiotic therapy and outcome in bacterial meningitis: a Danish population-based cohort study , 2016, BMC Infectious Diseases.

[7]  D. Matthews,et al.  Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes , 2014, Diabetes Care.

[8]  E. Vermeire,et al.  The concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic review , 2014, BMC Family Practice.

[9]  G. Constantine,et al.  Therapeutic momentum: a concept opposite to therapeutic inertia , 2013, International journal of clinical practice.

[10]  S. Pita-Fernández,et al.  Is There a Predictive Profile for Clinical Inertia in Hypertensive Patients? , 2011, Drugs & aging.

[11]  D. Belletti,et al.  A narrative review of clinical inertia: focus on hypertension. , 2009, Journal of the American Society of Hypertension : JASH.

[12]  M. Moser Physician or Clinical Inertia: What Is It? Is It Really a Problem? And What Can Be Done About It? , 2009, Journal of clinical hypertension.

[13]  G Reach,et al.  Patient non-adherence and healthcare-provider inertia are clinical myopia. , 2008, Diabetes & metabolism.

[14]  Brian J Zikmund-Fisher,et al.  The Role of Clinical Uncertainty in Treatment Decisions for Diabetic Patients with Uncontrolled Blood Pressure , 2008, Annals of Internal Medicine.

[15]  V. Durkalski,et al.  Therapeutic Inertia Is an Impediment to Achieving the Healthy People 2010 Blood Pressure Control Goals , 2006, Hypertension.

[16]  J. Saver Time Is Brain—Quantified , 2006, Stroke.

[17]  William Branch,et al.  Clinical Inertia , 2001, Annals of Internal Medicine.

[18]  M. Hand,et al.  When time is muscle. , 2000, The American journal of nursing.